Oorsprong van het eerstegraads netwerk van John M. Krayacich
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John M. Krayacich via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AKSYS LTD. | Financial Conglomerates | Director/Board Member | |
VERICEL CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Kaleo, Inc.
Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Chairman | |
Applied Intelligent Systems, Inc.
Applied Intelligent Systems, Inc. Medical SpecialtiesHealth Technology Part of MKS Instruments, Inc., Applied Intelligent Systems, Inc. is a company that manufactures machine vision computers. The company is based in Ann Arbor, MI. Applied Intelligent Systems was acquired by Electro Scientific Industries, Inc., part of MKS Instruments, Inc. from February 01, 2019 on December 02, 1997 for $60.55 million. | Medical Specialties | Corporate Officer/Principal | |
Esperance BioVentures LLC
Esperance BioVentures LLC Investment ManagersFinance Founded in 1998 by Roger Newton and Timothy Mayleben, Esperance BioVentures LLC is a venture capital firm located in Ann Arbor, Michigan | Investment Managers | Founder | |
Michigan Ross Zell Lurie Institute / Venture Capital/
Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan. | Investment Managers | Corporate Officer/Principal | |
Wolverine Venture Fund
Wolverine Venture Fund Investment ManagersFinance Wolverine Venture Fund, an evergreen fund invests in companies located in the US. The fund targets companies that are affiliated with the University of Michigan and operating in the fields of biomedicine, healthcare IT, advanced materials, and other emerging technologies. It provides financing for seed and early-stage capital requirements with an investment size ranging from $50,000 to $100,000 and also makes co-investment rights. | Investment Managers | Director/Board Member | |
Stephen M. Ross School of Business | College/University | Undergraduate Degree | |
LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin | |
LANDOS BIOPHARMA, INC. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 17 |
Sectoraal
Health Technology | 10 |
Finance | 5 |
Consumer Services | 3 |
Health Services | 2 |
Technology Services | 2 |
Operationeel
Director/Board Member | 12 |
Independent Dir/Board Member | 4 |
President | 4 |
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Sterkste connecties
Insiders | |
---|---|
Tim Mayleben | 18 |
- Beurs
- Insiders
- John M. Krayacich
- Bedrijfsconnecties